"Designing Growth Strategies is in our DNA"

Surgical Tourniquet Market Size, Share, and Industry Analysis By Type (Tourniquet Systems, Tourniquet Cuffs, and Tourniquet Accessories), By Application (Lower-Limb Surgery and Upper-Limb Surgery), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI112201

 

KEY MARKET INSIGHTS

The global surgical tourniquet market size was valued at USD 550.26 billion in 2025. The market is projected to grow from USD 594.84 billion in 2026 to USD 1109.25 billion by 2034, exhibiting a CAGR of 8.1% during the forecast period.

The global surgical tourniquet market is gaining significant impetus from the increasing demand for controlling hemorrhage during elective surgeries and emergency surgeries. These surgical tourniquets are medical apparatuses that arrest the blood flow during treatments for improved visibility for surgeons, which would cut down on blood losses especially in orthopedic as well as trauma surgeries.

  • According to the U.S. Food and Drug Administration, nearly 19,975 surgical procedures conducted every year in North America make use of tourniquets, thus indicative of the wider spectrum of application for clinical purposes.

Enhancing market adoption of the practice is the rising use of single-use tourniquet cuffs in public hospitals as well as the development of pneumatic systems that promote infection control and procedural efficiency.

Surgical Tourniquet Market Driver

Market Growth Driven By Trauma, Aging, Technology

The market as a whole is propelled by the increase in cases of trauma and road accidents around the world, where tourniquets are an important element in the management of hemorrhages. According to the European Medicines Agency, there are 1,548 injury-related emergency cases involving tourniquet applications reported annually in Europe alone. Moreover, the growing geriatric population that had orthopedic conditions and the technological advancement in surgical procedures would be increasing the adoption of products in emergency care and planned surgery.

Surgical Tourniquet Market Restraint

Regulatory Challenges And Safety Concerns Limit Market Growth

Challenges however exist for the surgical tourniquet market through stringent regulatory frameworks that require enormous testing and documentation, thereby delaying product approval and market release. There are also concerns of nerve damage or ischemia should tourniquets be improperly applied; these concerns can inhibit such adoption even for complex procedures. The safety issues further entrench the tourniquet as an unfavorable alternative to the other hemostatic procedures, including advanced surgical tools and techniques. These hindrances, therefore, constitute important limiting factors to systematic market growth.

Surgical Tourniquet Market Opportunity

Emerging Markets Drive Surgical Tourniquet Growth

The emerging markets are the best soil for providing expansion, as better healthcare infrastructure and surgical capabilities drive the demand for advanced medical devices. The movement toward disposable tourniquets also paves the way for new revenue from infection control initiatives. In addition, the adoption of intelligent features such as real-time monitoring and automation of pressure adjustments further beef up the functionality and safety of the products. Most probably, such innovations will arouse increased interest from surgical teams and healthcare institutions. Hence, the market stands to benefit from the technological and regional growth momentum.

Segmentation

By Type

By Application

By End-user

By Geography

● Tourniquet Systems

● Tourniquet Cuffs

● Tourniquet Accessories

● Lower-Limb Surgery

● Upper-Limb Surgery

● Hospitals & ASCs

● Specialty Clinics

● Others

● North America (U.S. and Canada)

● Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

● Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

● South America(Brazil, Mexico,and the Rest ofSouth America)

● Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Prevalence of Road Accidents and Trauma Cases, By Key Regions
  • Drivers, Restraints, Trends, and Opportunities in the Surgical Tourniquet Market
  • Healthcare Expenditure and Surgical Procedure Statistics, By Key Countries
  • Consolidated SWOT Analysis of Key Players in the Surgical Tourniquet Market
  • Key Industry Developments (Product Launches, Mergers, Acquisitions, and Partnerships)
  • Overview: Regulatory Scenario and Safety Compliance
  • Growth of Geriatric Population and Its Impact on Surgical Tourniquet Demand

Analysis by Type

By type, the market is divided into tourniquet systems, tourniquet cuffs, and tourniquet accessories.

The surgical tourniquet market is expected to dominate itself for tourniquet systems due to their role in controlling bleeding in surgical settings, especially in emergencies. Integration with other advanced features, such as automatic pressure sets and safety systems, is contributing to their acceptance. With improvements in reliability and efficacy due to technological elements, this segment will observe huge growth in the near future.

Tourniquet cuffs that maintain pressure during surgical procedures are expected to record considerable market growth. The heightened concern about infection control and safety in healthcare settings has fueled the rise in demand for high-quality cuffs, especially disposable ones. Increasingly, surgical volumes worldwide are expected to see this segment gain considerable growth in the upcoming years.

Analysis by Application

By application, the market is divided into lower-limb surgery and upper-limb surgery.

Lower-limb surgery, including joint replacement procedures and orthopedic surgeries, is expected to dominate the field of tourniquets. The segment has benefitted from a rapidly increasing number of procedures and the need for good control over blood flow during surgeries. With the aging population winds, the number of orthopedic uses will increase, hence the increased call for lower-limb surgeries for the use of tourniquets.

Upper-limb surgery, though decreasing, is expected to show considerable growth in relation to the market for tourniquets. Certain procedures such as those performed on the arm and hand will have a tourniquet put on to control hemorrhage effectively. With the improvement of advanced surgical techniques and the vast proliferation of the use of advanced medical devices, the growth of this segment is projected to be steady into the future.

Analysis by End-user

By end-user, the market is divided into hospitals & ASCs, specialty clinics, and others.

Farsightedly, hospitals and ASCs are dominating as far as the market is concerned, owing to a more significant number of surgical procedures conducted. Growth in this area is enhanced by associated advances in surgical technology and healthcare funding. With hospitals and ASCs unwaveringly committed to good surgical outcomes and patient safety, this segment is predicted to witness considerable growth.

The specialty clinics, especially orthopedic and trauma care, are expected to record substantial growth. In these settings, the demand for surgical tourniquets increases chiefly due to the rising incidence of specialized surgeries. As specialty clinics expand and address a more focused clientele, that segment is expected to see colossal growth in the years to come.

Regional Analysis

Based on geography, the market has been studied across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

To gain extensive insights into the market, Download for Customization

The demand for surgical tourniquets in North America will be sustained, having propagated by an advanced healthcare structure and early acceptance of innovations in medical technology. Frequent orthopedic procedures, primarily concerning joint replacements, are driving the constant demand from hospitals and surgical centers. With existing regulations concerning support and innovations in surgery, the region is likely to retain its dominance in the coming years.

The surgical tourniquet market in Europe is now showing signs of steady growth due to a rapidly aging population and hence increasing incidences of orthopedic conditions requiring surgical care. The vital emphasis on patient safety in the region pushes for precision-based advanced tourniquet systems. The area has considerable relevance in this regard and is expected to act as a booster to the growth of the global market, which is expected to continue onwards.

Asia-Pacific is emerging as a high-growth gas region, with rising healthcare expenditure and improved access to surgical care in the developing world. Growing trauma cases or cases of road accidents are also more concerning about the demand for solid hemorrhage control means such as tourniquets. The improvements in medical infrastructure are expected to create the fastest growth in this territory in the next years.

Key Players Covered

The report includes the profiles of the following key players:

  • Zimmer Biomet (U.S.)
  • Stryker (U.S.)
  • ulrich GmbH & Co. KG (Germany)
  • Hammarplast Medical AB (Sweden)
  • AneticAid (United Kingdom)
  • Delfi Medical Innovations Inc. (Canada)
  • Rudolf Riester GmbH (Germany)
  • Medtronic (Ireland)

Key Industry Developments

  • In March 2024, the introduction of the SAM XT Tourniquet to the market, from SAM Medical, it has also been endorsed by the Committee on Tactical Combat Casualty Care (CoTCCC) of the U.S. Department of Defense. This tourniquet has been intended mainly for fast application and adopts a TRUFORCE Buckle, which auto locks after reaching a certain force for the application of even pressure. It is now part of the STOP THE BLEED portfolio and signifies emergency addressing in critical times and through that assures tested reliability.
  • In May 2024, Emerging as a relevant player in the tactical emergency medical space, Tri-Tech Forensics, Inc., announced the acquisition of SAM Medical. The merger now calls for more innovation on surgical tourniquets and trauma management solutions while extending the range of Tri-Tech's products and giving Tri-Tech a better foothold in the global market.
  • In August 2024, Getinge USA Sales, LLC signed a strategic sales partnership agreement with SurgicalOne, Inc. The partnership is set to involve the promotion of the autofluorescence and fluorescence imaging technology of Fluoptics, which enhances the surgeon's skill during surgery intervention. Cooperating using this technology cannot enhance the distribution and adoption of innovative surgical imaging products at the same time not contribute to the development of new technologies in the area of tourniquets.


  • 2021-2034
  • 2025
  • 2021-2024
  • 128
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann